Summary
Goldman Sachs Group, Inc. (GS) filed an 8-K on February 6, 2012, reporting the successful expiration and solicitation of consents for two of its capital vehicles: Goldman Sachs Capital II and Goldman Sachs Capital III. The company announced that the consent solicitations for the 5.793% Fixed-to-Floating Rate Normal APEX notes from Capital II and the Floating Rate Normal APEX notes from Capital III were successful, following an initial announcement on January 9, 2012. This filing primarily serves to formally report on the outcome of these solicitations, indicating positive engagement from noteholders.
Key Highlights
- 1Successful consent solicitation for Goldman Sachs Capital II's 5.793% Fixed-to-Floating Rate Normal APEX notes.
- 2Successful consent solicitation for Goldman Sachs Capital III's Floating Rate Normal APEX notes.
- 3The consent solicitations expired on or around February 5, 2012.
- 4This action follows an initial announcement of the consent solicitations on January 9, 2012.
- 5The company is the sponsor of both Goldman Sachs Capital II and Goldman Sachs Capital III.
- 6The filing includes the press release announcing these results as Exhibit 99.1.
Frequently Asked Questions
The main purpose of this 8-K filing was to formally report on the successful outcome of consent solicitations for specific debt instruments issued by two of Goldman Sachs' capital vehicles, Goldman Sachs Capital II and Goldman Sachs Capital III.
Goldman Sachs Capital II and Goldman Sachs Capital III are financial vehicles or special purpose entities sponsored by The Goldman Sachs Group, Inc. They are used to issue various forms of debt or preferred equity to investors, often with specific risk and return profiles.
A successful consent solicitation means that the required percentage of noteholders agreed to the proposed changes or terms. In this context, it implies that Goldman Sachs was able to achieve its objectives regarding these specific notes, which could involve restructuring terms, maturities, or other conditions, without the need for further action or potential defaults.
The specific debt instruments involved were Goldman Sachs Capital II's 5.793% Fixed-to-Floating Rate Normal APEX notes and Goldman Sachs Capital III's Floating Rate Normal APEX notes.